<DOC>
	<DOC>NCT01755429</DOC>
	<brief_summary>This protocol is intended to formally collect data on the treatment of aHUS with eculizumab in Japanese patients.</brief_summary>
	<brief_title>To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hemolysis</mesh_term>
	<mesh_term>Azotemia</mesh_term>
	<mesh_term>Hemolytic-Uremic Syndrome</mesh_term>
	<mesh_term>Atypical Hemolytic Uremic Syndrome</mesh_term>
	<criteria>1. Patient and/or legal guardian must be willing and able to give written informed consent and id the patient is not an adult and able to read and write, the patient is willing to give written informed assent 2. Eculizumab treatment initiated as personal importation for aHUS in 201</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>